Catalyst Wire Dossier Catalyst Wire Dossier

Porcine placental extracellular matrix augmented therapy

porcine placental extracellular matrix · ConvaTec Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Porcine placental extracellular matrix augmented therapy, covering 2025-05-21 to 2025-05-21. Get the full timeline:

Most recent: Clinical Trial Update: IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers [NA]

See pricing